Loading…
Based on limited metadata, Holy Land Brand Inc. received an FDA Warning Letter on June 29, 2018, regarding an unspecified product category classified as "Other." Without access to the full letter text or specific subject line details, the exact nature of the violations cannot be determined from the available information. The issuing FDA office is also not specified in the metadata provided. To understand the specific regulatory concerns and required corrective actions, the complete Warning Letter text would be necessary.